← Back to Patent Explorer
US4309339A Expired / Lapsed US ⏱️ 0.0 years remaining

Leucine-rich 3,1-S-α2 -glycoprotein, process for isolating it and its use

Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1979-12-14
•
Granted: 1982-01-05
•
Expires: 1999-12-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New glycoprotein having the following properties: a sedimentation constant in the ultracentrifuge of 3.1 S+/-0.2; molecular weight 49,600+/-4,000; electrophoretic mobility in the range of the alpha 2-globulins of the human serum; isoelectric range pH 3.8 to 4.1; extinction coefficient E 1 cm, 280 nm=1% 7.0+/-0.2; content of about 77+/-2% of alpha -amino acids with a proportion of 17+/-2% of leucine and about 22% of carbohydrates; specific immunological reaction with antibodies directed against the glycoprotein; which can be isolated from human sera and which may be used for the preparation of antisera enabling the detection and determination of the glycoprotein in body fluids.

Inventors

  • 👤 Heinz Haupt
  • 👤 Siegfried Baudner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 14:48
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/16; C; C07; C07K; C07K14/00; C07K14/435; C07K14/46; C07K14/47; C07K14/4701; C07K14/473; C07K16/00; C07K16/18; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; A61K38/00; A61K39/00; Y; Y10; Y10S; Y10S436/00; Y10S436/822; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 151 words
Glycoprotein isolated from human serum, characterized by the following parameters: (a) sedimentation constant in the ultracentrifuge 3.1 S±0.2; (b) molecular weight of 49,000±4,000; (c) electrophoretic mobility in the range of the α 2 -globulins of the human serum; (d) isoelectric range pH 3.8-4.1; (e) extinction coefficient E 1 cm 1% , 280 nm=7.0±0.2; (f) content of about 77%±2% of α-amino-acids and about 23%±2% of carbohydrates, and of said amino acids and carbohydrates, the major fractions being present as follows: ______________________________________ Mole % of the amino-acid pro- Variation Amino Acids portion coefficient % ______________________________________ Aspartic acid 11.45 1.49 Serine 6.43 2.36 Glutamic acid 10.72 2.51 Proline 7.04 4.43 Glycine 7.32 2.31 Alanine 6.65 1.97 Leucine 22.05 5.79 ______________________________________ Carbohydrate Residues % by weight ______________________________________ Galactose 4.1 ± 0.3 Mannose 3.8 ± 0.3 N-Acetylhexosamine 8.1 ± 0.5 N-Acetylneuraminic acid 6.6 ± 0.4 ______________________________________ (g) specific immunological reactions with antibodies directed against the glycoprotein.
Claim 2
Dependent Claim 151 words
Glycoprotein isolated from human serum, characterized by the following parameters: (a) sedimentation constant in the ultracentrifuge 3.1 S±0.2; (b) molecular weight of 49,000±4,000; (c) electrophoretic mobility in the range of the α 2 -globulins of the human serum; (d) isoelectric range pH 3.8-4.1; (e) extinction coefficient E 1 cm 1% , 280 nm=7.0±0.2; (f) content of about 77%±2% of α-amino-acids and about 23%±2% of carbohydrates, and of said amino acids and carbohydrates, the major fractions being present as follows: ______________________________________ Mole % of the amino-acid pro- Variation Amino Acids portion coefficient % ______________________________________ Aspartic acid 11.45 1.49 Serine 6.43 2.36 Glutamic acid 10.72 2.51 Proline 7.04 4.43 Glycine 7.32 2.31 Alanine 6.65 1.97 Leucine 22.05 5.79 ______________________________________ Carbohydrate Residues % by weight ______________________________________ Galactose 4.1 ± 0.3 Mannose 3.8 ± 0.3 N-Acetylhexosamine 8.1 ± 0.5 N-Acetylneuraminic acid 6.6 ± 0.4 ______________________________________ (g) specific immunological reactions with antibodies directed against the glycoprotein.
Claim 3
Dependent Claim 188 words
Glycoprotein isolated from human serum, characterized by the following parameters: (a) sedimentation constant in the ultracentrifuge 3.1 S±0.2; (b) molecular weight of 49,000±4,000; (c) electrophoretic mobility in the range of the α 2 -globulins of the human serum; (d) isoelectric range pH 3.8-4.1; (e) extinction coefficient E 1 cm 1% , 280 nm=7.0±0.2; (f) content of about 77%±2% of α-amino-acids and about 23%±2% of carbohydrates, said amino acids and carbohydrates being present as follows: ______________________________________ Mole % of the amino-acid pro- Variation Amino Acids portion coefficient % ______________________________________ Lysine 3.87 5.90 Hystidine 2.23 11.28 Arginine 4.65 7.68 Aspartic acid 11.45 1.49 Threonine 3.87 6.26 Serine 6.43 2.36 Glutamic acid 10.72 2.51 Proline 7.04 4.43 Glycine 7.32 2.31 Alanine 6.65 1.97 1/2 Cystine 1.21 9.83 Valine 4.48 3.78 Methionine 0.75 5.81 Isoleucine 1.29 3.16 Leucine 22.05 5.79 Tyrosine 0.81 19.53 Phenylalanine 3.23 1.39 Tryptophane 1.60 11.69 ______________________________________ Carbohydrate Residues % by weight ______________________________________ Galactose 4.1 ± 0.3 Mannose 3.8 ± 0.3 Glucose 0 Fucose 0.3 ± 0.1 Xylose 0 N-Acetylhexosamine 8.1 ± 0.5 N-Acetylneuraminic acid 6.6 ± 0.4 ______________________________________ (g) specific immunological reactions with antibodies directed against the glycoprotein.
Claim 4
Dependent Claim 188 words
Glycoprotein isolated from human serum, characterized by the following parameters: (a) sedimentation constant in the ultracentrifuge 3.1 S±0.2; (b) molecular weight of 49,000±4,000; (c) electrophoretic mobility in the range of the α 2 -globulins of the human serum; (d) isoelectric range pH 3.8-4.1; (e) extinction coefficient E 1 cm 1% , 280 nm=7.0±0.2; (f) content of about 77%±2% of α-amino-acids and about 23%±2% of carbohydrates, said amino acids and carbohydrates being present as follows: ______________________________________ Mole % of the amino-acid pro- Variation Amino Acids portion coefficient % ______________________________________ Lysine 3.87 5.90 Hystidine 2.23 11.28 Arginine 4.65 7.68 Aspartic acid 11.45 1.49 Threonine 3.87 6.26 Serine 6.43 2.36 Glutamic acid 10.72 2.51 Proline 7.04 4.43 Glycine 7.32 2.31 Alanine 6.65 1.97 1/2 Cystine 1.21 9.83 Valine 4.48 3.78 Methionine 0.75 5.81 Isoleucine 1.29 3.16 Leucine 22.05 5.79 Tyrosine 0.81 19.53 Phenylalanine 3.23 1.39 Tryptophane 1.60 11.69 ______________________________________ Carbohydrate Residues % by weight ______________________________________ Galactose 4.1 ± 0.3 Mannose 3.8 ± 0.3 Glucose 0 Fucose 0.3 ± 0.1 Xylose 0 N-Acetylhexosamine 8.1 ± 0.5 N-Acetylneuraminic acid 6.6 ± 0.4 ______________________________________ (g) specific immunological reactions with antibodies directed against the glycoprotein.
Claim 5
Dependent Claim 135 words
Process for the isolation of the protein claimed in claim 1, wherein a solution containing said protein is subjected to a combination of the following steps to obtain it in pure form, as demonstrated immunologically whereafter, in each step, the fraction containing said protein is isolated, and the end product recovered after the last step: (a) addition of a water-soluble salt of an acridine base up to a concentration of 0.01 moles per liter at a neutral or weakly alkaline pH to precipitate accompanying proteins; (b) addition of a neutral salt until the protein precipitates; (c) adsorption of the protein on an anion exchanger and elution from it; (d) molecular sieve fractionation and isolation of proteins having a molecular weight of between 45,000 and 55,000; and (e) adsorption of accompanying proteins with water-insoluble calcium phosphate-hydrate.
Claim 6
Dependent Claim 182 words
Process for the isolation of the protein claimed in claim 1, wherein a solution containing said protein is subjected to a combination of the following steps to obtain it in pure form, as demonstrated immunologically whereafter, in each step, the fraction containing said protein is isolated, and the end product recovered after the last step: (a) addition of a neutral salt until the protein precipitates; (b) addition of an organic solvent until accompanying proteins are precipitated; (c) addition of a water-soluble salt of an acridine base until precipitation of accompanying proteins; (d) addition of an organic acid until precipitation of accompanying proteins; (e) heating to a temperature of between 95° to 100° C. until precipitation of accompanying proteins; (f) reduction of the electrolyte content until precipitation of accompanying proteins; (g) molecular sieve fractionation and isolation of the proteins having a molecular weight of between 45,000 and 55,000; (h) adsorption of the protein on an anion exchanger and elution from it; (i) electrophoresis and isolation of the α 2 -zone of human serum; and (k) adsorption of accompanying proteins with water-insoluble calcium phosphate-hydrate.
Claim 7
Dependent Claim 170 words
Glycoprotein isolated from human serum, prepared according to the process of claim 4 and further characterized by the following parameters: (a) sedimentation constant in the ultracentrifuge 3.1 S±0.2; (b) molecular weight of 49,000±4,000; (c) electrophoretic mobility in the range of the α 2 -globulins of the human serum; (d) isoelectric range pH 3.8-4.1; (e) extinction coefficient E 1 cm 1% , 280 nm=7.0±0.2; (f) content of about 77%±2% of a α-amino-acids and about 23%±2% of carbohydrates, and of said amino acids and carbohydrates, the major fractions being present as follows: ______________________________________ Mole % of the amino-acid pro- Variation Amino Acids portion coefficient % ______________________________________ Aspartic acid 11.45 1.49 Serine 6.43 2.36 Glutamic acid 10.72 2.51 Proline 7.04 4.43 Glycine 7.32 2.31 Alanine 6.65 1.97 Leucine 22.05 5.79 ______________________________________ Carbohydrate Residues % by weight ______________________________________ Galactose 4.1 ± 0.3 Mannose 3.8 ± 0.3 N-Acetylhexosamine 8.1 ± 0.5 N-Acetylneuraminic acid 6.6 ± 0.4 ______________________________________ (g) specific immunological reactions with antibodies directed against the glycoprotein, which demonstrates the presence of said isolated glycoprotein.

References Cited (Backward Citations)

US4191533A Cited
US4041021A Cited
US3928580A Cited
US4217339A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-01-04 1985-07-06 1986-01-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-01-04 1989-07-06 1990-01-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-01-04 1993-07-06 1994-01-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag